- Email:
Neuron related Microelectrode Array (MEA) Measurement Service
Introduction
Microelectrode arrays enable non-invasive, simultaneous recording of neuronal electrical activity. Recent studies support ultra-high-density MEA systems for mapping 3D neural networks. Creative Biolabs uses this technology to monitor live neuronal activity and support CNS therapeutic evaluation with high spatiotemporal resolution.
Our MEA service provides long-term, non-invasive functional recording and AI-powered signal analysis. It quantifies firing rates, burst patterns, and synaptic connectivity, enabling sensitive neurotoxicity assessment and drug efficacy validation to support reliable CNS drug development.
Discover How We Can Help - Request a Consultation →
Neuron related MEA Measurement Service
MEA (Microelectrode Array) Measurement enables real-time, non-invasive recording of extracellular electrical signals from neuronal networks. It captures key functional parameters, including firing rate, burst activity, network synchrony, and synaptic transmission, providing a direct functional readout of neuronal health, maturation, and activity.
Key Advantages
- Non-invasive and label-free detection that maintains the physiological viability of neurons and neural networks
- Long-term dynamic monitoring for chronic drug exposure and toxicity assessment
- High sensitivity to subtle changes in electrophysiological function
- Compatible with 2D neurons, iPSC-derived models, and 3D brain organoids
- Quantitative, objective, and highly reproducible functional data
Typical Applications
- Neurotoxicity screening of drugs, chemicals, and environmental compounds
- Evaluation of neuronal network maturation and function
- Assessment of drug efficacy on neurological disease models
- Mechanistic studies of synaptic transmission and neural circuit activity
- Preclinical safety profiling and regulatory support
Workflow
The process is designed to be seamless, requiring minimal initial setup from the client while providing exhaustive data at completion.
What We Can Offer
At Creative Biolabs, we understand that every neuro-scientific inquiry is unique. We provide a highly customizable and rigorous service portfolio designed to exceed the expectations of biology experts and pharmaceutical researchers. Our advantage lies in our combination of industrial-scale capability and precision biological engineering.
Customized Assay Design
Fully tailored experimental protocols designed to meet your specific research objectives, from disease-in-a-dish modeling to proprietary compound validation.
UHD-CMOS Platform Capability
Access to ultra-high-density arrays with over 236,000 electrodes, providing unparalleled spatial resolution for tracking axonal signals and sub-cellular activity.
Expert Cell Line Optimization
We optimize culture conditions, media components, and substrate coatings to maximize the functional maturity and phenotypic stability of your specific neuronal models.
Advanced Assembloid Engineering
Sophisticated fusion and recording services for region-specific organoids (e.g., cortical-striatal), enabling the study of inter-regional connectivity and projection pathways.
Strict Quality-by-Design (QbD)
All recordings are governed by a well-established quality system, ensuring rigorous baseline stability assessments and reproducible signal-to-noise ratios.
All-side AI Signal Decoding
Utilization of proprietary algorithms for high-throughput spike sorting, burst analysis, and the calculation of novel endpoints like propagation velocity.
Full Documentation & Regulatory Support
High-standard quality control tools and detailed data reporting to support your IND filings and clinical trial transitions.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Case Study
To investigate functional responses in human midbrain organoids derived from iPSCs, researchers performed immunofluorescence staining and UHD-CMOS MEA recording. Immunostaining confirmed the expression of mature neuronal marker MAP2 and dopaminergic marker TH. MEA analysis detected spontaneous electrical activity and network bursts, indicating the formation of functional neural circuits. Cumulative L-DOPA application dose-dependently increased total firing rate. Single-cell resolution MEA revealed heterogeneous cellular responses, with an increased proportion of activated neurons and decreased suppressed cells at higher concentrations. These results demonstrate that high-resolution MEA measurement enables reliable evaluation of drug-induced electrophysiological changes in 3D midbrain organoids at both network and single-cell levels.
Fig.1 Analysis of single-cell discharges in midbrain organoids.1
Customer Reviews
FAQs
Q: How does MEA compare to traditional patch-clamp electrophysiology?
A: While patch-clamp offers high-resolution single-cell data, it is labor-intensive and low-throughput. MEA provides high-throughput, network-level data and allows for non-invasive, longitudinal studies over weeks, which is impossible with patch-clamp.
Q: Can you perform measurements on 3D brain organoids?
A: Yes. Our UHD-CMOS MEA platform is specifically optimized for 3D structures, enabling "Field Potential Imaging" to visualize activity deep within organoid layers and across assembloid "bridges."
Q: What is the minimum number of compounds required for a screen?
A: We accommodate both small-scale pilot studies (1-5 compounds) and high-throughput screens. Please inquire about specific plate layout options.
Q: Is it possible to use patient-derived iPSCs for these assays?
A: Yes. Patient-specific disease modeling is one of our core strengths, allowing for personalized medicine approaches and the study of rare genetic neurological disorders.
Q: How do you handle data noise and signal artifacts?
A: We utilize advanced AI-driven spike sorting and filtering algorithms to ensure high signal-to-noise ratios, even in complex co-culture environments involving glia and neurons.
Creative Biolabs provides end-to-end MEA Measurement of Neuron services, including cell maturation, UHD-CMOS recording, AI-powered data decoding, and functional reporting. Our platform is the gold standard for neuropharmacology, toxicity testing, and organoid intelligence research.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Yokoi, Remi, et al. "Advanced neural activity mapping in brain organoids via field potential imaging with ultra-high-density CMOS microelectrode arrays." Frontiers in Neuroscience 19 (2025): 1634582. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fnins.2025.1634582.
For Research Use Only. Not For Clinical Use.